180 related articles for article (PubMed ID: 17896990)
1. Biology of PPAR gamma in cancer: a critical review on existing lacunae.
Krishnan A; Nair SA; Pillai MR
Curr Mol Med; 2007 Sep; 7(6):532-40. PubMed ID: 17896990
[TBL] [Abstract][Full Text] [Related]
2. PPARγ against tumors by different signaling pathways.
Zhang Z; Xu Y; Xu Q; Hou Y
Onkologie; 2013; 36(10):598-601. PubMed ID: 24107916
[TBL] [Abstract][Full Text] [Related]
3. [PPARgamma and cancer].
Nakagama H
Nihon Rinsho; 2010 Feb; 68(2):323-9. PubMed ID: 20158104
[TBL] [Abstract][Full Text] [Related]
4. Can PPAR gamma ligands be used in cancer therapy?
Rumi MA; Ishihara S; Kazumori H; Kadowaki Y; Kinoshita Y
Curr Med Chem Anticancer Agents; 2004 Nov; 4(6):465-77. PubMed ID: 15579013
[TBL] [Abstract][Full Text] [Related]
5. 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ).
Tan BS; Kang O; Mai CW; Tiong KH; Khoo AS; Pichika MR; Bradshaw TD; Leong CO
Cancer Lett; 2013 Aug; 336(1):127-39. PubMed ID: 23612072
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
[TBL] [Abstract][Full Text] [Related]
7. The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity.
Yousefnia S; Momenzadeh S; Seyed Forootan F; Ghaedi K; Nasr Esfahani MH
Gene; 2018 Apr; 649():14-22. PubMed ID: 29369787
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma and lung cancer biology: implications for therapy.
Roman J
J Investig Med; 2008 Feb; 56(2):528-33. PubMed ID: 18317436
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome Proliferator-Activated Receptor-γ and Its Ligands in the Treatment of Tumors in the Nervous System.
Shen Y; Lu Y; Yu F; Zhu C; Wang H; Wang J
Curr Stem Cell Res Ther; 2016; 11(3):208-15. PubMed ID: 26216127
[TBL] [Abstract][Full Text] [Related]
10. The role of peroxisome proliferator-activated receptor-γ in breast cancer.
Kotta-Loizou I; Giaginis C; Theocharis S
Anticancer Agents Med Chem; 2012 Nov; 12(9):1025-44. PubMed ID: 22583414
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic Effects of PPARγ Agonists, with a Special Focus on Thyroid Cancer.
Ferrari SM; Materazzi G; Baldini E; Ulisse S; Miccoli P; Antonelli A; Fallahi P
Curr Med Chem; 2016; 23(7):636-49. PubMed ID: 26844838
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) as a Target for Concurrent Management of Diabetes and Obesity-Related Cancer.
Wang Q; Imam MU; Yida Z; Wang F
Curr Pharm Des; 2017; 23(25):3677-3688. PubMed ID: 28677503
[TBL] [Abstract][Full Text] [Related]
13. Involvement of insulin-like growth factor binding protein-3 in peroxisome proliferator-activated receptor gamma-mediated inhibition of breast cancer cell growth.
Pon CK; Firth SM; Baxter RC
Mol Cell Endocrinol; 2015 Jan; 399():354-61. PubMed ID: 25449421
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.
Vallée A; Lecarpentier Y
Front Immunol; 2018; 9():745. PubMed ID: 29706964
[TBL] [Abstract][Full Text] [Related]
15. [The role of peroxisome proliferators-activated receptors (PPARgamma) in neoplasms of endocrine glands].
Winczyk K
Endokrynol Pol; 2008; 59(2):156-66. PubMed ID: 18465691
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment with peroxisome proliferator-activated receptor (PPAR) gamma ligands and gamma radiation induces apoptosis by PPARγ-independent up-regulation of reactive oxygen species-induced deoxyribonucleic acid damage signals in non-small cell lung cancer cells.
Han EJ; Im CN; Park SH; Moon EY; Hong SH
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e239-48. PubMed ID: 23332223
[TBL] [Abstract][Full Text] [Related]
17. Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells.
Leung WK; Bai AH; Chan VY; Yu J; Chan MW; To KF; Wu JR; Chan KK; Fu YG; Chan FK; Sung JJ
Gut; 2004 Mar; 53(3):331-8. PubMed ID: 14960510
[TBL] [Abstract][Full Text] [Related]
18. Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression.
Rovito D; Gionfriddo G; Barone I; Giordano C; Grande F; De Amicis F; Lanzino M; Catalano S; Andò S; Bonofiglio D
Oncotarget; 2016 Oct; 7(40):65109-65124. PubMed ID: 27556298
[TBL] [Abstract][Full Text] [Related]
19. Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer.
Li MY; Yuan H; Ma LT; Kong AW; Hsin MK; Yip JH; Underwood MJ; Chen GG
Am J Respir Cell Mol Biol; 2010 Dec; 43(6):674-83. PubMed ID: 20081051
[TBL] [Abstract][Full Text] [Related]
20. PPARgamma and early human placental development.
Fournier T; Thérond P; Handschuh K; Tsatsaris V; Evain-Brion D
Curr Med Chem; 2008; 15(28):3011-24. PubMed ID: 19075649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]